These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 792623)

  • 1. [Therapy of coronary heart disease using Cormelian-Digotab: influence of the duration of therapy. 2. Field study by 107 physicians].
    Pollter J; Schnitker J
    Med Welt; 1976 Oct; 27(43):2074-9. PubMed ID: 792623
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of coronary heart disease using Cormelian-Digotab. First communication on a field experiment of 107 residential physicians].
    Pollter J; Schnitker J
    Med Welt; 1975 Oct; 26(44):2007-12. PubMed ID: 1186488
    [No Abstract]   [Full Text] [Related]  

  • 3. [Administration of cormelian in coronary insufficiency. Results of a double blind study].
    Bremer P; Dölle P; Pollter J; Schnitker J; Schumacher KM
    Med Monatsschr; 1975 Dec; 29(12):577-80. PubMed ID: 1107787
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the bioavailability of the individual components from a combination of dilazep and beta-acetyldigoxin (author's transl)].
    Schaumlöffel E; Prignitz R
    Arzneimittelforschung; 1976; 26(12):2208-13. PubMed ID: 1037278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Report on the clinical testing of Cormelian-Digotab].
    Pollter J
    Med Welt; 1974 Nov; 25(48):2015-21. PubMed ID: 4617836
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of coronary heart disease using Cormelian-Digotab. Results of a double blind study].
    Messerich J
    Fortschr Med; 1974 Nov; 92(33):1367-71. PubMed ID: 4457447
    [No Abstract]   [Full Text] [Related]  

  • 7. Contemporaneous administration of digitalis and dilazep to subjects with heart failure of ischemic etiology.
    Pasotti C; Gandolfi P; Ottolenghi L
    Int J Clin Pharmacol Ther Toxicol; 1983 Jul; 21(7):370-3. PubMed ID: 6885209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The influence of intravenous administration of dilazep, beta-acetyldigoxin and dilazep/beta-acetyldigoxin on myocardial contractility in dogs].
    Zechel VH; Brock N
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1920-6. PubMed ID: 4480355
    [No Abstract]   [Full Text] [Related]  

  • 9. [Results of the clinical testing of a new coronary drug, Cormelian].
    Pollter J
    Fortschr Med; 1972 Apr; 90(10):399-404. PubMed ID: 4616888
    [No Abstract]   [Full Text] [Related]  

  • 10. [Efficiency of Cormelian in coronary insufficiency. Results of a double-blind study].
    Gillner H; Pollter J; Schnitker J; Sievers HG; Zylmann G
    Med Monatsschr; 1975 Feb; 29(2):82-7. PubMed ID: 1092990
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cormelian (Dilazep) a new coronary active substance].
    Reuter H
    Z Allgemeinmed; 1974 Oct; 50(28):1255-6. PubMed ID: 4614598
    [No Abstract]   [Full Text] [Related]  

  • 12. Controlled clinical trial of propranolol alone and in combination with dilazep in patients with angina pectoris.
    Biswas NR; Pandhi P; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1990 Jun; 28(6):241-4. PubMed ID: 2198233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The toxicology of the combination drug dilazep/beta-acetyldigoxin].
    Abel VH; Brock N; Pohl J; Zechel HJ
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1914-20. PubMed ID: 4480354
    [No Abstract]   [Full Text] [Related]  

  • 14. [Simultaneous administration of digoxin and diltiazem in patients with cardiac insufficiency and coronary heart disease].
    Pfeiffer G
    Fortschr Med; 1985 Jul; 103(26):699-702. PubMed ID: 3899880
    [No Abstract]   [Full Text] [Related]  

  • 15. [Noninvasive quantitative evaluation of cardiac reverse--effects of dilazep (adenosine like agent)].
    Morishita T; Arai C; Abe N; Takeuchi K; Hasegawa M; Takayama Y; Emori I; Yoshinori K
    Kokyu To Junkan; 1988 Jun; 36(6):675-9. PubMed ID: 3217607
    [No Abstract]   [Full Text] [Related]  

  • 16. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 3. Influence of the duration of therapy and co-medication on the therapeutic result. Secondary effects and discontinuation of therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1873-9. PubMed ID: 4155950
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of cardiac and coronary insufficiency with Digi-Baxacor].
    Vorberg G
    Ther Ggw; 1974 Jun; 113(6):1008-16. PubMed ID: 4849984
    [No Abstract]   [Full Text] [Related]  

  • 18. [Statistical evaluation of a cooperative study toward investigation of the effectiveness of the coronary stimulant dilazep in ischemic heart disease. 2. The importance of anamnestic and diagnostic characteristics for successful therapy].
    Schneider VB; Feldmann U; von Brachel H; Schnitker J; Gelbhaar H
    Arzneimittelforschung; 1974 Nov; 24(11A Suppl):1864-72. PubMed ID: 4615714
    [No Abstract]   [Full Text] [Related]  

  • 19. [Polycentric and hemodynamic experimentation with a new coronary active drug: dilazep].
    Baldrighi V; Barbaresi F; Plancher AC; Portioli I
    Clin Ter; 1976 Aug; 78(4):303-62. PubMed ID: 795597
    [No Abstract]   [Full Text] [Related]  

  • 20. [Experience with Segontin-Digoxin in the treatment of coronary and myocardial insufficieny. Short report].
    Schneider H
    Z Allgemeinmed; 1975 Nov; 51(31):1428. PubMed ID: 1199174
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.